Daclatasvir Impurity F

Daclatasvir Impurity F Structure
CAS No.
1007884-60-7
Chemical Name:
Daclatasvir Impurity F
Synonyms
Daclatasvir Impurity 40;Monodes(N-carboxymethyl)valine Daclatasvir;methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-{5-[4-(4-{2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl}phenyl)phenyl]-1H-imidazol-2-yl}pyrrolidin-1-yl]butan-2-yl]carbamate;Methyl ((S)-3-methyl-1-oxo-1-((S)-2-(5-(4''-(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1''-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)butan-2-yl)carbamate;Carbamic acid, N-[(1S)-2-methyl-1-[[(2S)-2-[5-[4'-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]-, methyl ester;Daclatasvir impurity 14/Monodes(N-carboxymethyl)valine Daclatasvir/N-[(1S)-2-Methyl-1-[[(2S)-2-[5-[4’-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1’-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]carbamic Acid Methyl Ester
CBNumber:
CB03154294
Molecular Formula:
C33H39N7O3
Molecular Weight:
581.71
MOL File:
1007884-60-7.mol
Modify Date:
2024/7/2 8:54:57

Daclatasvir Impurity F Properties

Boiling point 963.0±65.0 °C(Predicted)
Density 1.239±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
form Solid
pka 11.22±0.46(Predicted)
color White to off-white

Daclatasvir Impurity F Chemical Properties,Uses,Production

Uses

Monodes(N-carboxymethyl)valine Daclatasvir is an impurity of Daclatasvir (D101500); a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV).

Daclatasvir Impurity F Preparation Products And Raw materials

Raw materials

Preparation Products

Daclatasvir Impurity F Suppliers

Global( 33)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Varanous Labs Pvt Ltd +91-7036248882 +91-7036248882 Hyderabad, India 1541 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
sgtlifesciences pvt ltd +8617013299288 China 12382 58 Inquiry
China National Standard Pharmaceutical Corporation Limited +8615391658522 China 11927 58 Inquiry
Shanghai Famo Biotech Co Ltd +86-36680037 +86-18550473860 China 528 58 Inquiry
United States Biological 800.520.3011 or 781.639.5092 United States 6256 80 Inquiry
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233; 18502726233 China 9808 58 Inquiry
Monodes(N-carboxymethyl)valine Daclatasvir Daclatasvir impurity 14/Monodes(N-carboxymethyl)valine Daclatasvir/N-[(1S)-2-Methyl-1-[[(2S)-2-[5-[4’-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1’-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]carbamic Acid Methyl Ester methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-{5-[4-(4-{2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl}phenyl)phenyl]-1H-imidazol-2-yl}pyrrolidin-1-yl]butan-2-yl]carbamate Daclatasvir Impurity 40 Methyl ((S)-3-methyl-1-oxo-1-((S)-2-(5-(4''-(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1''-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)butan-2-yl)carbamate Carbamic acid, N-[(1S)-2-methyl-1-[[(2S)-2-[5-[4'-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]-, methyl ester 1007884-60-7 C33H39N7O3